The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription

BMC Molecular Biology

Volumn 7, Issue , 2006, Pages

  James, Claudine G ^a,b   Woods, Anita ^a,b   Underhill, T Michael ^a,c   Beier, Frank ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CYCLIN A; CYCLIN D1; CYTOCHALASIN D; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CHONDROGENESIS; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; EMBRYO; FEMALE; GENE REPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROMOTER REGION; RECEPTOR DOWN REGULATION;

ACTINS; ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIN A; CYCLIN D1; CYTOCHALASIN D; FEMALE; HIGH MOBILITY GROUP PROTEINS; MALE; MICE; MODELS, BIOLOGICAL; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33749548543     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-7-30     Document Type: Article

References (67)

1. van der Eerden BCJ, Karperien M, Wit JM: Systemic and Local Reguladon of the Growth Plate. Endocr Rev 2003, 24(6):782-801.
2. Kronenberg HM: Developmental regulation of the growth plate. Nature 2003, 423(6937):332-336.
3. Ballock RT, O'Keefe RJ: Physiology and pathophysiology of the growth plate. Birth Defects Res C Embryo Today 2003, 69(2):123-143.
4. Hoffman LM, Weston AD, Underhill TM: Molecular Mechanisms Regulating Chondroblast Differentiation. J Bone Joint Surg Am 2003, 85(90002):124-132.
5. Lefebvre V, Smits P: Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005, 75(3):200-212.
6. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B: The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002, 16(21):2813-2828.
7. Karsenty G: Minireview: transcriptional control of osteoblast differentiation. Endocrinology 2001, 142(7):2731-2733.
8. Reimold AM, Grusby MJ, Kosaras B, Fries JW, Mori R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glimcher MJ, Glimcher LH: Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 1996, 379(6562):262-265.
9. Long F, Schipani E, Asahara H, Kronenberg H, Montminy M: The CREB family of activators is required for endochondral bone development. Development 2001, 128(4):541-550.
10. Ionescu AM, Schwarz EM, Vinson C, Puzas JE, Rosier R, Reynolds PR, O'Keefe RJ: PTHrP modulates chondrocyte' differentiation through AP-1 and CREB signaling. J Biol Chem 2001, 276(15):11639-11647.
11. Beier F, Taylor AC, LuValle P: Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. J Biol Chem 2000, 275(17):12948-12953.
12. Beier F, Lee RJ, Taylor AC, Pestell RG, LuValle P: Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondroytes. Proc Natl Acad Sci U S A 1999, 96(4):1433-1438.
13. Beier F, Ali Z, Mok D, Taylor AC, Leask T, Albanese C, Pestell RG, LuValle P: TGFbeta and PTHrP Control Chondrocyte Proliferation by Activating Cyclin D1 Expression. Mol Biol Cell 2001, 12(12):3852-3863.
14. Halawani D, Mondeh R, Stanton LA, Beier F: p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation. Oncogene 2004, 23(20):3726-3731.
15. Beier F, LuValle P: The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia. Mol Endocrinol 2002, 16(9):2163-2173.
16. Persengiev SP, Green MR: The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 2003, 8(3):225-228.
17. Hai T, Hartman MG: The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273(1):1-11.
18. Pan Y, Chen H, Siu F, Kilberg MS: Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple ATF3 mRNA species which, when overexpressed in HepG2 cells, modulate transcription by the human Asparagine synthetase promoter. J Biol Chem 2003, 278(40):38402-12.
19. Hagmeyer BM, Duyndam MC, Angel P, de Groot RP, Verlaan M, Elfferich P, van der Eb A, Zantema A: Altered AP-1/ATF complexes in adenovirus-E1-transformed cells due to EIA-dependent induction of ATF3. Oncogene 1996, 12(5):1025-1032.
20. Kool J, Hamdi M, Cornelissen-Steijger P, van der Eb AJ, Terleth C, van Dam H: Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin 1, stress-induced MAPkinases and ATF-2. Oncogene 2003, 22(27):4235-4242.
21. Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H, Zhu X, Mazzacurati L, Li X, Petrik KL, Fornace AJJ, Rajasekaran B, Zhan Q: ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 2002, 21(49):7488-7496.
22. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M: Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 2006, 21(1):18-28.
23. Huo JS, McEachin RC, Cui TX, Duggal NK, Hai T, States DJ, Schwartz J: Profiles of Growth Hormone (GH)-regulated Genes Reveal Time-dependent Responses and Identify a Mechanism for Regulation of Activating Transcription Factor 3 By GH. J Biol Chem 2006, 281(7):4132-4141.
24. Bakin AV, Stourman NV, Sekhar KR, Rinehart C, Yan X, Meredith MJ, Arteaga CL, Freeman ML: Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med 2005, 38(3):375-387.
25. Nilssen LS, Odegard J, Thoresen GH, Molven A, Sandnes D, Christoffersen T: G protein-coupled receptor agonist-stimulated expression of ATF3/ LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation. J Cell Physiol 2004, 201(3):349-358.
26. Chen BP, Liang G, Whelan J, Hai T: ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 1994, 269(22):15819-15826.
27. Allan AL, Albanese C, Pestell RG, LaMarre J: Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J Biol Chem 2001, 276(29):27272-27280.
28. Perez S, Vial E, van Dam H, Castellazzi M: Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation. Oncogene 2001, 20(9):1135-1141.
29. Ishiguro T, Nagawa H, Naito M, Tsuruo T: Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells. Jpn J Cancer Res 2000, 91(8):833-836.
30. Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T: The Roles of ATF3 in Glucose Homeostasis. A TRANSGENIC MOUSE MODEL WITH LIVER DYSFUNCTION AND DEFECTS IN ENDOCRINE PANCREAS. J Biol Chem 2001, 276(31):29507-29514.
31. Lu D, Wolfgang CD, Hai T: Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis. J Biol Chem 2006, 281(15):10473-10481.
32. Nobori K, Ito H, Tamamori-Adachi M, Adachi S, Ono Y, Kawauchi J, Kitajima S, Marumo F, Isobe M: ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol 2002, 34(10):1387-1397.
33. James CG, Appleton CTG, Ulici V, Underhill TM, Beier F: Microarray Analyses of Gene Expression during Chondrocyte Differrentiation Identifies Novel Regulators of Hypertrophy. Mol Biol Cell 2005, 16(11):5316-5333.
34. Woods A, Wang G, Beier F: RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J. Biol Chem 2005, 280(12):11626-11634.
35. Woods A, Beier F: RhoA/ROCK Signaling Regulates Chondrogenesis in a Context-dependent Manner. J Biol Chem 2006, 281(19):13134-13140.
36. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS: Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001, 15(21):2865-2876.
37. Kondo S, Murakami T, Tatsumi K, Ogata M, Kanemoto S, Otori K, Iseki K, Wanaka A, Imaizumi K: OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes. Nat Cell Biol 2005, 7(2):186-194.
38. Haze K, Yoshida H, Yanagi H, Yura T, Mori K: Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999, 10(11):3787-3799.
39. Li M, Baumeister P, Roy B, Phan T, Foti D, Luo S, Lee AS: ATF6 as a transcription activator of the endoplasmic reticulum stress element: thapsigargin stress-induced changes and synergistic interactions with NF-Y and YYI. Mol Cell Biol 2000, 20(14):5096-5106.
40. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, Prywes R: Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem 2000, 275(35):27013-27020.
41. Yoshida H, Haze K, Yanagi H, Yura T, Mori K: Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 1998, 273(50):33741-33749.
42. Beier F: Cell-cycle control and the cartilage growth plate. J Cell Physiol 2005, 202(1):1-8.
43. LuValle P, Beier F: Cell cycle control in growth plate chondrocytes. Front Biosci 2000, 5:D493-503.
44. Li TF, Zuscik MJ, Ionescu AM, Zhang X, Rosier RN, Schwarz EM, Drissi H, O'Keefe RJ: PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res 2004, 300(1):159-169.
45. Benya PD: Modulation and reexpression of the chondrocyte phenotype; mediation by cell shape and microfilament modification. Pathol Immunopathol Res 1988, 7(1-2):51-54.
46. Loty S, Forest N, Boulekbache H, Sautier JM: Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol Cell 1995, 83(2-3):149-161.
47. Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T: ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem 1996, 271(3):1695-1701.
48. Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Berges J, Helin K, Jansen-Durr P, Henglein B: Cell cycle regulation of the cyclin A gene promoter is mediated by avariant E2F site. Proc Natl Acad Sci U S A 1995, 92(24):11264-11268.
49. Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Durr P:. Activation of the E2F transcription factor by cyclin D1 is blocked by p161NK4, the product of the putative tumor suppressor gene MTS1. Oncogene 1994, 9(12):3475-3482.
50. Huang W, Lu N, Eberspaecher H, de Crombrugghe B: A New Long Form of c-Maf Cooperates with Sox9 to Activate the Type 11 Collagen Gene. J Biol Chem 2002, 277(52):50668-50675.
51. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, Sudbeck P, Scherer G, Poulat F, Berta P: Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 1998, 18(11):6653-6665.
52. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B: Interactions between Sox9 and {beta}-catenin control chondrocyte differentiation. Genes Dev 2004, 18(9):1072-1087.
53. Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y: Nrf2 Negatively Regulates Osteoblast Differentiation via Interfering with Runx2-dependent Transcriptional Activation. J Biol Chem 2006, 281(26):18015-18024.
54. Selvamurugan N, Kwok S, Alliston T, Reiss M, Partridge NC: Transforming Growth Factor-{beta} 1 Regulation of Collagenase-3 Expression in Osteoblastic Cells by Cross-talk between the Smad and MAPK Signaling Pathways and Their Components, Smad2 and Runx2. J Biol Chem 2004, 279(18):19327-19334.
55. Xiao G, Jiang D, Ge C, Zhao Z, Lai Y, Boules H, Phimphilai M, Yang X, Karsenty G, Franceschi RT: Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression. J Biol Chem 2005, 280(35):30689-30696.
56. Thomas DM, Johnson SA, Sims NA, Trivett MK, Slavin JL, Rubin BP, Waring P, McArthur GA, Walkley CR, Holloway AJ, Diyagama D, Grim JE, Clurman BE, Bowtell DDL, Lee JS, Gutierrez GM, Piscopo DM, Carty SA, Hinds PW: Terminal osteoblast differentiation, mediated by runx2 and p27K1P1, is disrupted in osteosarcoma. J Cell Biol 2004, 167(5):925-934.
57. Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS, van Wijnen AJ: The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts. J Biol Chem 2005, 280(21):20274-20285.
58. Qiao M, Shapiro P, Fosbrink M, Rus H, Kumar R, Passaniti A: Cell Cycle-dependent Phosphorylation of the RUNX2 Transcription Factor by cdc2 Regulates Endothelial Cell Proliferation. J Biol Chem 2006, 281(11):7118-7128.
59. Pratap, J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi JY, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ: Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts. Cancer Res 2003, 63(17):5357-5362.
60. Shen R, Wang X, Drissi H, Liu F, O'Keefe RJ, Chen D: Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation. J Biol Chem 2006, 281(24):16347-16353.
61. Weston AD, Chandraratna RA, Torchia J, Underhill TM: Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. J Cell Biol 2002, 158(1):39-51.
62. Wang J, Cao Y, Steiner DF: Regulation of Proglucagon Transcription by Activated Transcription Factor (ATF) 3 and a Novel Isoform, ATF3b, through the cAMP-response Element/ATF Site of the Proglucagon Gene Promoter. J Biol Chem 2003, 278(35):32899-32904.
63. Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG: Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A 1996, 93(23):12861-12866.
64. Nakamura T, Okuyama S, Okamoto S, Nakajima T, Sekiya S, Oda K: Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp Cell Res 1995, 216(2):422-430.
65. Appleton CT, James CG, Beier F: Regulator of G-protein signaling (RGS) proteins differentially control chondrocyte differentiation. J Cell Physiol 2006.
66. Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F: p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 2004, 378(Pt 1):53-62.
67. Wang G, Woods A, Sabari S, Pagnotta L, Stanton LA, Beier F: RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J Biol Chem 2004, 279(13):13205-13214.